Canonical ingredient
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino) ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
FLURAZEPAM HYDROCHLORIDE
20 linked products
Official identifiers
Names and synonyms
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino) ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride (en)
- Flurazepam hydrochloride (en)
- Chlorhydrate de flurazépam (fr)
- 7-chloro-1-[2-(diéthylamino)éthyl]-5-(2-fluorophényl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one, dichlorhydrate (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
BIO-FLURAZEPAM
15 · MG
BIO-FLURAZEPAM
30 · MG
DALMANE
15 · MG
DALMANE
30 · MG
FLURAZEPAM
15 · MG
FLURAZEPAM
30 · MG
FLURAZEPAM 15
15 · MG
FLURAZEPAM 15MG CAPSULE
15 · MG · CAP
FLURAZEPAM 30
30 · MG
FLURAZEPAM 30MG CAPSULE
30 · MG · CAP
NOVO-FLUPAM CAP 15MG
15 · MG
NOVO-FLUPAM CAP 30MG
30 · MG
PMS-FLURAZEPAM CAP 15MG
15 · MG
PMS-FLURAZEPAM CAP 30MG
30 · MG · CAP
RIVA-FLURAZEPAM 15MG CAPSULES
15 · MG · CAP
RIVA-FLURAZEPAM 30MG CAPSULES
30 · MG · CAP
SOM-PAM
15 · MG
SOM-PAM
30 · MG
SOMNOL 15MG
15 · MG
SOMNOL 30MG
30 · MG